As the Chinese New Year approaches, the production of the COVID-19 vaccines is of great urgency, and its packaging needs to keep up with the pace in order to prevent the outbreak.On December 31th, 2020, the first COVID-19 vaccine was approved to be marketed in China with conditions. A number of other COVID-19 vaccine have also been carried out phase III clinical trials in overseas countries, and the research and development of the vaccine has entered the sprint phase and is ready for mass production.
2021-02-05As the Chinese New Year approaches, the production of the COVID-19 vaccines is of great urgency, and its packaging needs to keep up with the pace in order to prevent the outbreak.On December 31th, 2020, the first COVID-19 vaccine was approved to be marketed in China with conditions. A number of other COVID-19 vaccine have also been carried out phase III clinical trials in overseas countries, and the research and development of the vaccine has entered the sprint phase and is ready for mass production.
